UCB SA

UCB SA

World Rank (Aug-2026)
533
Market Cap (Aug-2026)
48.562 Billion USD
World Rank (Jan-05-2024)
1,055
Market Cap (Jan-05-2024)
16.926 Billion USD
World Rank (Jul-30-2023)
1,073
Market Cap (Jul-30-2023)
17.074 Billion USD
World Rank (Jan-07-2022)
1,006
Market Cap (Jan-07-2022)
20.612 Billion USD
World Rank (Jan-01-2021)
930
Market Cap (Jan-01-2021)
19.456 Billion USD
Headquarters Country
Belgium
Top Healthcare Companies in Europe
Top Technology Companies in Europe
Top Pharmaceutical Companies in Europe
CEO
Jean-Christophe Tellier
Employee Count
8,703
Employee Count as of Date
As on 2022
World Region
Europe
World Subregion
Western Europe
Annual Revenue in USD
9,180 Million USD
Annual Operating Income in USD
2,377 Million USD
Annual Net Income in USD
1,848 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
21,535 Million USD
Total Liabilities in USD
8,647 Million USD
Total Equity in USD
12,888 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Pharmaceutical
Biopharmaceutical
Biotechnology
Technology
Company Website
UCB
Wikipedia
Wikipedia
Yahoo
Yahoo @ Brussels
Company Profile
UCB is a global biopharmaceutical company focusing on creating value for people living with neurology and immunology conditions. Headquartered in Brussels, Belgium. As on 2019, UCB has Total revenue of 4.9 billion EUR and has more than 7,600 employees.
Founded Year
1928
ISIN Code
BE0003739530
Stock Category
EURONEXT 100
S&P EUROPE 350
Stock Exchange
EURONEXT

Share